Wound Treatments in the United Kingdom
Euromonitor International's Wound Treatments in the United Kingdom market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 28 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Other wound treatments; Sticking plasters
Table of contents
WOUND TREATMENTS IN THE UNITED KINGDOM : MARKET INSIGHT
HEADLINES
SECTOR DATA
Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 3 Wound Treatments Company Shares by Value 2004-2008
Table 4 Wound Treatments Brand Shares by Value 2005-2008
Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - UNITED KINGDOM
BAYER PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Bayer Plc: Key Facts
Summary 2 Bayer Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Bayer Plc: Competitive Position 2008
GLAXOSMITHKLINE PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 4 GlaxoSmithKline Plc: Key Facts
Summary 5 GlaxoSmithKline Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 GlaxoSmithKline: Competitive Position 2008
RECKITT BENCKISER PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Reckitt Benckiser Plc: Key Facts
Summary 8 Reckitt Benckiser Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Reckitt Benckiser Plc: Competitive Position 2008
OTC HEALTHCARE IN THE UNITED KINGDOM
EXECUTIVE SUMMARY
OTC healthcare market remains stable despite economic slump
Smokers and elderly continue to bolster market
Market remains dominated by megabrands
Shoppers continue to shift to supermarkets
Recession expected to bypass OTC healthcare market
KEY TRENDS AND DEVELOPMENTS
John Bull faces bear market
Fat is the new thin
Consumers cherish their chains
National Stealth Service
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 8 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 11 OTC Healthcare Company Shares by Value 2004-2008
Table 12 OTC Healthcare Brand Shares by Value 2005-2008
Table 13 Penetration of Private Label by Sector 2003-2008
Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 10 OTC Healthcare Switches 2005-2007
DEFINITIONS
Sources
Summary 11 Research Sources